Cardiovascular disease risk tied to vision loss in Latino adults

In the U.S., Hispanic/Latino populations are disproportionately at risk for eye diseases like glaucoma and diabetic retinopathy, or vision loss tied to diabetes. But the association between heart and eye health in Hispanic/Latino people remains underresearched, says Dr. Charlotte Joslin, University of Illinois at Chicago professor of ophthalmology.

In a study published in JAMA Network Open, Joslin and her team have examined vision and cardiovascular health data from more than 3,000 Hispanic/Latino adults. The results indicate an association between cardiovascular disease risk factors, like diabetes, and visual impairment.

“Normally, we tend to think of eye health as distinct from the rest of the body. These results reveal a relationship between cardiovascular disease risk factors and visual impairment,” said Joslin, who is also affiliated with the epidemiology and biostatistics department in the School of Public Health.

In 2019, Joslin led a study that examined eye disease in Hispanic/Latino communities.

The six-year study looked at data from 3,294 adults ages 40 and older (about 60 years old on average) in Chicago and Miami. All participants belong to the Hispanic Community Health Study/Study of Latinos, a cohort of 16,000 participants that is the basis for broad research on Hispanic/Latino populations and health.

Participants in Joslin’s study identified as Central American, Cuban, Mexican, Puerto Rican, South American or another unspecified background. Each participant received state-of-the-art eye examinations.

“First, we measure the vision with which participants walk into the office: their day-to-day eyesight with whatever lenses they normally use or don’t use. Then, we determine the best each participant’s vision could possibly be with the proper corrective eyewear,” Joslin said.

The latter metric can help identify eye disease, specifically in patients who are still visually impaired despite corrective eyewear. The researchers also tracked when corrective lenses were outdated, incorrect or absent altogether.

Participants were also assessed for diabetes, high cholesterol, obesity, smoking and high blood pressure—all risk factors for cardiovascular disease.

Joslin said participants with more risk factors—three or four, perhaps, instead of one or none—were more likely to be visually impaired. Previous studies have linked single conditions, such as diabetes, to visual impairments, but none have acknowledged the effect of compounded factors.

“If you were just diagnosed with diabetes, that’s one risk factor. But many of these risk factors tend to go together. This study tells us that people who have three risk factors—for example, diabetes, high cholesterol and hypertension—have a much greater risk for visual impairment than those with just one risk factor, such as diabetes,” Joslin said.

Results also revealed differences among participants with different backgrounds. For example, men who identified as Mexican were four to six times more likely to be visually impaired than other groups.

“We cannot treat everyone the same. Recognizing heterogeneity across Hispanic/Latino backgrounds is so important for targeted treatments and care,” Joslin said.

Visual impairment was also associated with lower socioeconomic status, educational level and income, a preference for Spanish versus English and limited access to health care.

Joslin said the associations between cardiovascular disease risk factors and eye health identified in this study are not causal and must be contextualized within the experiment; for example, this study’s focus on Hispanic/Latino adults and the tendency of healthier individuals to volunteer for scientific studies.

Who’s behind this story?

Stephanie Baum

Master’s in TESOL from The New School. Passionate about language learning and editing science news on biology and space exploration.

Full profile →

Advertisements

Andrew Zinin

Master’s in physics with research experience. Long-time science news enthusiast. Plays key role in Science X’s editorial success.

Full profile →

See also  Using advanced imaging to improve brain cancer treatment